Files and links (1)
Published, Version of Record (VoR)CC BY V4.0, Open
Journal article
Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer
Curēus (Palo Alto, CA), v 11(2), pe4024
07 Feb 2019
PMID: 31007982
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Tumor lysis syndrome (TLS) is a fatal complication of chemotherapy treatment. It is rarely seen in the treatment of solid tumors particularly in breast cancer. We presented the case of a chemo-naïve 58-year-old Caucasian woman who developed tumor lysis syndrome (TLS) after a single treatment dose of gemcitabine for metastatic breast cancer. Despite optimal management, the patient clinically deteriorates and is referred to inpatient hospice. Although targeted chemotherapy options have become increasingly effective, physicians should be aware of the rare, yet often fatal complications of TLS. Similarly, physicians should be able to quickly recognize the development of TLS to ensure swift and effective prophylaxis or treatment.
Metrics
12 Record Views
Details
- Title
- Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer
- Creators
- Hafiz M Aslam - Seton Hall UniversityCassandra Zhi - Drexel UniversitySara L Wallach - Seton Hall University
- Publication Details
- Curēus (Palo Alto, CA), v 11(2), pe4024
- Publisher
- Cureus
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:000461529800001
- Other Identifier
- 991019167894204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology